Splicing markup

By Richard Grant Splicing markup Julie Blencowe The paper: R.F. Luco et al., “Regulation of alternative splicing by histone modifications,” Science, 327:996–1000, 2010. (ID: 2000983) The finding: Alternative splicing, or the shuffling of exons that ultimately become an mRNA message, is one of the “last of the fundamental gene expression mechanisms we don’t understand,” said Tom Misteli from t

Written byRichard Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

R.F. Luco et al., “Regulation of alternative splicing by histone modifications,” Science, 327:996–1000, 2010. (ID: 2000983)

The finding:

Alternative splicing, or the shuffling of exons that ultimately become an mRNA message, is one of the “last of the fundamental gene expression mechanisms we don’t understand,” said Tom Misteli from the National Cancer Institute in Bethesda. His group showed that epigenetic changes—methylation and acetylation of histones—govern that process.

The twist:

Since previous studies had shown that splicing was affected by the speed of DNA transcription, Misteli hypothesized that histone modifications might slow transcription, and therefore affect splicing. His lab, however, found that chromatin affected not the speed, but the selection of splice sites: methylation of lysine 36 on histone H3, for example, promotes the inclusion of exons regulated by the PTB protein.

The puzzle:

But how was the message transmitted from the DNA-bound histones to RNA? After talking to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies